Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications hifmech study group plasminogen activator inhibitor 1 675 4g5g genotype influences risk
… Rachel Weinrib Pharmacoepidemiology and Risk Management Barcelona, Spain MPH University of California … Manager within the Epidemiology Research Group at RTI-HS. Ms. Weinrib completed a Master’s in Public … She has extensive experience coordinating multinational study teams and expertise in reproductive health …
… employees below. If this approach to rewarding work and study matches your values and your sense of purpose and …
… Years of Research Share on: September 30, 2020 On October 1, 2000, RTI Health Solutions was officially launched under … Access and Outcomes Strategy Pharmacoepidemiology and Risk Management Biostatistics Real-World Evidence HTA and …
… Anam Khan Pharmacoepidemiology and Risk Management Waltham, Massachusetts, USA PhD, Epidemiology … in the Pharmacoepidemiology and Risk Management group with RTI-HS. Dr. Khan has over 7 years of experience in … data analysis and interpretation, and producing study reports, as well as disseminating information to …
… evaluating disease natural history and incidence of and risk factors for rare adverse outcomes potentially associated … large multidisciplinary teams involved in these complex study designs. He has broad experience developing study components while harmonizing the information received …
… Merck and RTI Health Solutions designed and conducted a study to compare rates of disease occurrence before vaccines were available with current disease rates. The study considered 14 diseases that are covered in … death, pediatric immunization is cost saving. A separate study including researchers from Merck and RTI Health …
… data they need is accurately captured prior to beginning a study. Follow this link to read the details of this study. …
Gene Therapy Keep your gene therapy development on track The paradigm of regenerative medicine development is changing. Expedited regulatory approvals can help developers, but only if they are timely with strategic planning and fully versed in the latest …
… is a Director in the Patient-Centered Outcomes Assessment group at RTI-HS. Dr. Olayinka-Amao has experience in all … (as well as those designed for electronic administration), study protocols, technical reports, and regulatory documents … reviews, analyzing statistical data, interpreting study results, conducting interviews and focus groups, …
… Economist and Head in the Health Preference Assessment group at RTI-HS, where she conducts stated-preference studies … quality protection, recreation experiences, and terrorism risk. Dr. Mansfield has extensive experience with …